Background/Aims: The A3 adenosine receptor antagonist reversine (2-(4-morpholinoanilino)-6-cyclohexylaminopurine) influences cellular differentiation, inhibits cell proliferation, induces cell-cycle arrest, triggers apoptosis, causes cell swelling with polyploidy and stimulates autophagy. The effect on apoptosis involves mitochondria and caspases. Erythrocytes are lacking mitochondria but express caspases and are, similar to apoptosis of nucleated cells, able to enter suicidal erythrocyte death or eryptosis. Stimulators of eryptosis include increase of cytosolic Ca 2+ activity ([Ca 2+ ] i ), energy depletion and oxidative stress. The present study explored, whether reversine influences eryptosis. Methods: Flow cytometry was employed to quantify phosphatidylserine exposure at the cell surface from annexin-V-binding and cell volume from forward scatter. Measurements were made without or with energy depletion (glucose deprivation for 48 hours), Ca 2+ loading (30 minutes treatment with 1 µM Ca 2+ ionophore ionomycin), or oxidative stress (15 min exposure to 0.3 mM tert-butylhydroperoxide). Results: A 48 hours exposure of human erythrocytes to reversine (1-10 µM) did not significantly modify the percentage of annexin-V-binding cells and forward scatter. Energy depletion, Ca 2+ loading, and oxidative stress were each followed by profound and significant increase of the percentage annexin-V-binding erythrocytes and a significant decrease of forward scatter. The effects of each, Ca 2+ loading, energy depletion and oxidative stress on annexin-V-binding were significantly blunted in the presence of reversine (1-10 µM). The effect of ionomycin, but not the effects of energy depletion and oxidative stress on forward scatter were again significantly blunted in the presence of reversine (≥1 µM]. Conclusions: Reversine is a powerful inhibitor of cell membrane scrambling following energy depletion, Ca 2+ loading and oxidative stress.
Introduction
The purine analog [1] [2] [3] [4] [5] [6] [7] [8] [9] and A3 adenosine receptor antagonist [10, 11] , reversine (2-(4-morpholinoanilino)-6-cyclohexylaminopurine) reverses differentiation of lineagecommitted cells to mesenchymal stem cells (MSCs) allowing them to undergo differentiation ] i ) [33] , ceramide [89] , G-protein Galphai2 [90] , and several kinases including activated casein kinase 1α, Janusactivated kinase JAK3, protein kinase C, and p38 kinase [33] , or inactivated AMP activated kinase AMPK, cGMP-dependent protein kinase, PAK2 kinase, mitogen and stress activated kinase MSK1/2 [91] and sorafenib/sunitinib sensitive kinases [33] .
The present study explored, whether reversine is able to trigger eryptosis and/or is able to modify eryptosis triggered by cellular Ca 2+ load, energy depletion or oxidative stress. To this end, human erythrocytes from healthy volunteers were exposed to Ca 2+ ionophore ionomycin, glucose deprivation or the oxidant tert-butyl-hydroperoxide and phosphatidylserine surface abundance as well as cell volume determined by flow cytometry.
Materials and Methods

Erythrocytes, solutions and chemicals
Fresh Li-Heparin-anticoagulated blood samples were kindly provided by the blood bank of the University of Tübingen. The study is approved by the ethics committee of the University of Tübingen (184/2003 V). The blood was centrifuged at 120 g for 20 min at 21 °C and the platelets and leukocytes-containing supernatant was disposed. Erythrocytes were incubated in vitro at a hematocrit of 0.4% in Ringer solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO 4 , 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES; pH 7.4), 5 glucose, 1 CaCl 2 , at 37°C for 48 hours. Where indicated, erythrocytes were exposed for 48 hours to glucose containing or glucose depleted Ringer solution, for 30 minutes to Ca 2+ ionophore ionomycin (1 µM, Merck
Results
The present study explored, whether reversine stimulates or interferes with eryptosis, the suicidal erythrocyte death. The two hallmarks of eryptosis, i.e. cell shrinkage and phospholipid scrambling of the cell membrane with phosphatidylserine translocation to the cell surface were determined by flow cytometry. Phosphatidylserine exposing erythrocytes were identified utilizing annexin-V-binding to phosphatidylserine, cell shrinkage was quantified utilizing forward scatter. Moreover, we explored the effect of reversine on cell granularity unsing the side scatter.
In a first series of experiments erythrocytes were incubated for 48 hours in the absence or presence of reversine. As illustrated in Fig. 1 , the percentage of annexin-V-binding erythrocytes was low following a 48 hours exposure to glucose containing Ringer solution with or without addition of reversine (1 -10 µM). Accordingly, up to 48 hours, reversine did not appreciably modify phosphatidylserine abundance at the erythrocyte surface.
As further shown in Fig. 1 , a 48 hours exposure to glucose depleted Ringer solution was followed by a marked increase of the percentage of annexin-V-binding erythrocytes. The addition of reversine (1-10 µM) significantly blunted the increase of the percentage of annexin-V-binding erythrocytes following energy depletion. However, even in the presence of reversine, energy depletion significantly increased the percentage of phosphatidylserine exposing erythrocytes (Fig. 1) . The erythrocyte forward scatter was, following a 48 hours exposure to Ringer solution in the presence of glucose, virtually identical in the absence and presence of reversine (1 -10 µM).
Moreover, the erythrocyte side scatter in arbitrary units (a.u.) was virtually identical in the absence of reversine (201 ± 15 a.u., n = 20), at 1 µM reversine (195 ± 17 a.u., n = 20), at 5 µM reversine (203 ± 20 a.u., n = 20) and at 10 µM reversine (188 ± 18 a.u., n = 20).
Accordingly, up to 48 hours, reversine did not appreciably modify erythrocyte volume (Fig. 2) . A 48 hours exposure to glucose-depleted Ringer solution was followed by a marked decrease of forward scatter.
Again, the erythrocyte forward scatter was, following a 48 hours exposure to Ringer solution in the absence of glucose, virtually identical in the absence and presence of reversine (1 -10 µM). Accordingly, neither in energy replete nor in energy depleted erythrocytes did reversine influence significantly the erythrocyte volume.
Exposure of the erythrocytes for 30 minutes to 1 µM ionomycin was followed by a sharp increase of the percentage of annexin-V-binding erythrocytes (Fig. 3) . The effect was blunted in the presence of reversine, an effect reaching statistical significance at 5 µM reversine. However, even in the presence of 10 µM reversine, ionomycin significantly increased the percentage of phosphatidylserine exposing erythrocytes (Fig. 3) .
Exposure of the erythrocytes for 30 minutes to 1 µM ionomycin was followed by a sharp decrease of forward scatter (Fig. 4) . The cell shrinkage was blunted in the presence of reversine, an effect reaching statistical significance at 5 µM reversine. However, even in the presence of 10 µM reversine, ionomycin significantly increased the percentage of phosphatidylserine exposing erythrocytes (Fig. 4) . 
Cellular Physiology and Biochemistry
Similar to what has been observed following ionomycin treatment, exposure of the erythrocytes for 15 minutes to 0.3 mM tert-butyl-hydroperoxide was followed by a sharp increase of the percentage of annexin-V-binding erythrocytes (Fig. 5) . The effect was slightly blunted in the presence of reversine, an effect reaching statistical significance at 10 µM reversine. In the presence of 10 µM reversine, tert-butyl-hydroperoxide still significantly increased the percentage of phosphatidylserine exposing erythrocytes (Fig. 5) .
Exposure of the erythrocytes for 15 minutes to 0.3 mM tert-butyl-hydroperoxide was further followed by a decrease of forward scatter (Fig. 6) . The effect was not significantly modified by reversine and in the presence of 1-10 µM reversine, tert-butyl-hydroperoxide significantly increased the percentage of phosphatidylserine exposing erythrocytes (Fig. 6) .
Discussion
The present observations reveal the somewhat unexpected inhibitory effect of reversine on eryptosis, the suicidal erythrocyte death characterized by cell shrinkage and cell membrane scrambling with phosphatidylserine translocation to the erythrocyte surface [33] .
Reversine itself did not appreciably modify the percentage of phosphatidylserine exposing erythrocytes and cell volume, but significantly blunted the cell membrane scrambling following energy depletion, Ca 2+ loading and oxidative stress. All three maneuvers are well known stimulators of eryptosis [33] . [33] . Reversine fails to significantly blunt the cell shrinkage following energy depletion or oxidative stress. The mechanisms accounting for the reversine resistance of cell shrinkage following energy depletion and oxidative stress remained elusive.
At least in theory, the inhibition of eryptosis by reversine could be therapeutically exploited in the treatment of anemia due to enhanced eryptosis. Enhanced eryptosis is observed in diverse clinical conditions including iron deficiency [33] , dehydration [92] , hyperphosphatemia [93] , vitamin D excess [94] , chronic kidney disease (CKD) [95] [96] [97] [98] [99] [100] , hemolytic-uremic syndrome [101] , diabetes [102] , hepatic failure [103, 104] , malignancy [33, 105, 106] , sepsis [107] , sickle-cell disease [33] , beta-thalassemia [33] , Hb-C and G6PD-deficiency [33] , as well as Wilson´s disease [107] . The enhanced eryptosis leads to rapid clearance of the phosphatidylserine exposing erythrocytes from circulating blood [33] . Overt anemia is observed as soon as the loss of erythrocytes outcasts the formation of new erythrocytes by erythropoiesis [33] . Excessive eryptosis may further interfere with microcirculation [89, [108] [109] [110] [111] [112] , as phosphatidylserine exposing erythrocytes adhere to the vascular wall [113] , stimulate blood clotting and trigger thrombosis [108, 114, 115] . Inhibitors of eryptosis may counteract anemia and impairment of microcirculation in the above clinical conditions. It must be kept in mind, however, that inhibition of eryptosis may prevent the clearance of defective erythrocytes from circulating blood. The defective erythrocytes may instead undergo hemolysis [33] with release of hemoglobin which may pass the renal glomerular filter, precipitate in the acidic lumen of renal tubules, occlude nephrons and thus lead to renal failure [116] .
In contrast to its effect on eryptosis, reversine stimulates apoptosis [3, 5, 10, [23] [24] [25] [26] [27] . Mechanisms involved in the stimulation of apoptosis by reversine include inhibition of Akt/ mTORC1 signaling [88] , caspase activation [5, 10, 22, 88] , mitochondrial depolarization [22] , autophagy [3, 10, 88] and mitotic catastrophe [20, 25, 27] .
In conclusion, reversine suppresses the stimulation of cell membrane scrambling following energy depletion, Ca 2+ overload and oxidative stress. Reversine further interferes with the triggering of cell shrinkage following Ca 2+ overload, but not following energy depletion and oxidative stress. The potential therapeutic implications of the present observations remain to be defined.
